Texas Cardiac Arrhythmia Institute at St. David’s Medical Center First in Texas to Use New Smartphone Compatible, Insertable Cardiac Monitor

AUSTIN, Texas, Jan. 18, 2018 /PRNewswire/ — On Nov. 14, 2017, Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center became the first hospital in Texas—and among the first in the nation—to use the new smartphone compatible Confirm Rx™ Insertable Cardiac Monitor (ICM), the world’s first and only smartphone compatible ICM designed to help physicians […]

CorInnova Wins Top Prize at “RESI San Francisco 2018” Innovation Challenge

HOUSTON–(BUSINESS WIRE)–CorInnova Inc., an emerging medical device company developing breakthrough technology for the treatment of Heart Failure, announced today that it has won First Prize in the “RESI (Redefining Early Stage Investments) San Francisco 2018” investment competition for early-stage life science companies. “We are excited that early-stage investors instantly grasp the […]

iMedrix Announces General Availability of KardioScreen, a CE certified, Connected ECG Device for Universal Use

BANGALORE, January 5, 2018 /PRNewswire/ — iMedrix, a Silicon Valley and Bangalore-based mHealth start-up, announced the general availability of its product KardioScreen, a CE certified mobile/portable hospital grade digital ECG. KardioScreen is the first truly mobile, connected ECG solution that can be applied universally: field screening, point of care, ambulance, Cardiac ICU and […]

First Patient Enrolled in U.S. IDE Study To Evaluate the Potential of New Device To Reduce Stroke Risk in Atrial Fibrillation Patients

IRVINE, Calif., Jan. 11, 2018 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, enrolled the first patient in the WaveCrest® Investigational Device Exemption (IDE) Trial. The study will evaluate the safety and effectiveness of the WaveCrest® Left Atrial […]

CardioFocus Announces Expanded Partnership With Japan Lifeline

MARLBOROUGH, Mass., Jan. 9, 2018 /PRNewswire/ — CardioFocus Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), today announced that it has entered into an expanded partnership with Japan Lifeline. The expanded partnership solidifies the commercial strategy for bringing the HeartLight® Endoscopic […]

Endotronix Announces Successful First-in-Human Implantation of the Cordella Pulmonary Artery Pressure Sensor and Initiation of the SIRONA Clinical Trial

LISLE, Ill., Jan. 8, 2018 /PRNewswire/ — Endotronix, Inc., a medical technology company providing device and digital health solutions for heart failure management, today announced successful first-in-human implantation of the Cordella™ Pulmonary Artery (PA) Pressure Sensor and initiation of the SIRONA First-in-Human (FIH) clinical trial. Cardiologists Prof. Dr. Wilfried Mullens of Ziekenhuis Oost-Limburg and University Hasselt and […]

Sensifree Reports Statistically Significant Concordance of Arterial Pressure Signal Waveform Between its Continuous Non-invasive Blood Pressure Monitoring Technology and Invasive Arterial Line

CUPERTINO, Calif.–(BUSINESS WIRE)– Sensifree, a medical device company developing advanced RF-based hemodynamic monitoring solutions, announces results of a clinical study showing excellent concordance between the signal morphology of its RF based sensor and invasive arterial line, the standard of care for continuous blood pressure monitoring. Clinical data from the study further […]

BioSig Technologies Appoints New CFO to Facilitate Growth Trajectory

Santa Monica, CA, Jan. 03, 2018 (GLOBE NEWSWIRE) — BioSig Technologies(OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that Mr. Steven (Steve) Chaussy will be joining the company to serve in […]